Australian medical cannabis company MMJ PhytoTech Limited has just sold its first marijuana pills. The bad news: They are only available in Europe.

The capsules were sold in August via a Swiss-based subsidiary, Satipharm. 10 milligrams of the medication will set you back 89 euros (A$139.95).

The pills are registered as a dietary supplement in Germany. Their active ingredient, Cannabidiol (CBD), is made from a special medical cannabis strain and they do not contain tetrahydrocannabinol (THC), the chemical that causes most of marijuana's psychological effects when smoked.

Tweed Marijuana, a publicly traded medicinal marijuana company on the Toronto Stock Exchange-Venture board (TWD), announced Monday morning that the company had completed its merger with Bedrocan Cannabis in an all-stock deal valued at about CDN$61 million on the day the arrangement was first announced in June.

Tweed is Canada’s first publicly traded medical marijuana company and Bedrocan is a clinical research firm that claims to be one of only two companies in the world currently capable of producing standardized full-bud, pharmaceutical grade medicinal cannabis. Bedrocan operates as a division of Tweed, and Bedrocan’s shareholders own approximately 40% of the merged companies. Tweed shareholders own about 60%.

Province had sought court order to force child to go back on prescription drugs

The Alberta government has abruptly dropped its legal attempt to stop an Edmonton-area mother from treating her young daughter's epileptic seizures with marijuana.

"I didn't think they had the proper evidence to fight something that was working," Lita Pawliw told reporters while holding her daughter Natalya, 4, outside the courthouse in Leduc, a bedroom community south of Edmonton.

As first reported by CBC News early Friday, Alberta's Child and Family Services applied to a court for a supervision order that would have essentially taken control of the child's medical treatment.

Your friend that only smokes pure indica because sativa 'makes them paranoid?' Scientists have confirmed your sneaking suspicion that these dopers are just blowing smoke.

As any serious toker will point out, cannabis is among the planet's oldest cultivated crops. But driven underground, marijuana growth has been a genetic free-for-all, with cross-breeding mixing up even the most basic distinction — between indica and sativa — that many hold dear. 

The chief executive officer of the BC Pharmacy Association wants the newly regulated medical cannabis dispensaries in B.C. to be restricted from calling themselves "dispensaries."

Where have they been for the last 18 years?

While the new dispensary bylaws in Vancouver seem to trace out a distinction between non-profit "compassion clubs" and dispensaries, I don't think you'll be seeing too much confusion from Vancouverites on what exactly is being dispensed at these locations.

The right background tunes can help reinforce your brand and build consumer loyalty

Imagine walking into what’s described as a “trendy boutique” and being welcomed by out-of-date music or, even worse, silence. It’s the kind of mixed signal that could leave questioning why they decided to stop in at all.

Music is a mood-setter, with brands like Apple, Coca-Cola, and Molson leveraging music consistently in their brand-building efforts. But you don’t need to be a big brand to connect with customers through music. You simply need to make it a priority.

Province seeks court order to force child back on to prescription drugs

An Edmonton-area mother is challenging an attempt by the Alberta government to legally bar her four-year-old daughter from receiving a marijuana treatment the mother says has successfully quelled her daughter's debilitating epileptic seizures.

"I feel violated and bullied to take away the one thing that gives her a life," the mother told CBC News.

Neither she nor her daughter can be identified under a provincial law that forbids the identification of any child involved with Alberta Child and Family Services.

A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.

"Even though hemp and marijuana are important crops, knowledge about cannabis is lacking because of its status as a controlled drug," said Jonathan Page, a University of British Columbia botanist who co-led the first large-scale study of the genetic diversity of cannabis. The research was conducted together with Sean Myles, a population geneticist at Dalhousie University.

The National Cancer Institute (NCI) updated its website to include various studies revealing how cannabis may inhibit tumor growth by killing cells, blocking cell growth, and blocking the development of blood vessels that tumors need to grow. The institute released the following statement after updating its website:

“A laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells. Studies in mouse models of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.”

NIDA says cannabis kills cancer cells

Tests on marijuana from around the world show their genetic makeup may be far from different from their purported background.

“There’s a lot of confusion and a lot of chaos in the system now,” says Jonathan Page, a University of B.C. botanist who helped lead the first large-scale study of the genetic diversity of cannabis. His most recent work is published today in the online journal Plos One.

“Right now, the genetic identity of a marijuana strain cannot be accurately determined by its name or reported ancestry,” Page said in a news release. “Ultimately, we require a practical, accurate and more reliable classification system of this plant.”